LG3 Domain Peptide Integrin Binding Nerve Regeneration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The mechanism of PKC activation in integrin-mediated intracellular adhesion, migration, spreading, and signaling is not well understood, particularly regarding the receptor-binding motifs within the human laminin α2 chain's LG domains and their downstream signaling pathways.

Innovation Solution

Identification of the LG3 domain in the human laminin α2 chain as a key region promoting cell adhesion, spreading, migration, and neurite outgrowth through the membrane recruitment of PKCδ and FAK phosphorylation at Tyr-397, with a peptide sequence (e.g., SEQ ID NO:1) derived from this domain being used as a medicament for nerve regeneration and tissue engineering.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If the complete laminin α2 chain is used to promote cell adhesion and migration, then biological activity is high, but the complexity and cost of production increase

Engineering Contradiction:
Improvebiological activityVSAvoidmolecular complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The laminin α2 chain is divided into functional domains (LG1-LG5), and the invention identifies and isolates the specific LG3 domain as the minimal unit required for cell adhesion and migration activities. This segmentation allows using only the necessary portion rather than the complete complex molecule.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The active peptide sequence (RNIPPFEGCIWN) is extracted from the LG3 domain of the laminin α2 chain. This extraction creates a simplified peptide fragment that retains the essential biological function while eliminating unnecessary complexity from the parent molecule.

Inventive Principle:
Principle #2Taking out (Extraction)

2Ease of manufacture

If synthetic peptides are used instead of recombinant proteins, then production cost and complexity decrease, but manufacturing precision may be affected

Engineering Contradiction:
Improveproduction simplicityVSAvoidpeptide sequence accuracy
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The invention creates synthetic peptide copies of the critical adhesion sequence (RNIPPFEGCIWN) found in the LG3 domain. These synthetic copies can be produced through standard peptide synthesis methods, providing a simplified manufacturing approach while maintaining the essential sequence for biological activity.

Inventive Principle:
Principle #26Copying

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The LG3 domain peptide enhances cell adhesion, spreading, migration, and neurite outgrowth by binding to α3β1 integrin, recruiting PKCδ, and inducing FAK phosphorylation, making it suitable for nerve regeneration, tissue repair, and tissue engineering applications.

Implementation Method 1

Integrins are transmembrane adhesive receptors that mediate cell-cell and cell-extracellular matrix (ECM) interactions

Methodology Applied
Scientific EffectCell adhesion: Adhesive

Implementation Method 2

PKC is an important regulator of integrin-mediated signaling and cellular behavior, such as cell adhesion, spreading, migration, and focal adhesion formation

Methodology Applied
Scientific EffectProtein kinase C activation:

Implementation Method 3

the cytoplasmic domain that associates with focal adhesion kinase (FAK), Src-family kinases, and cytoskeleton-associated proteins

Methodology Applied
Scientific EffectPhosphorylation:

Data Source

PatentEP2500351B1Human laminin alpha-2 chain LG3 domain and active peptides promoting cell adhesion, spreading, migration, and neurite outgrowth
Publication Date: 2016.12.14 SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
  • EP2500351B1 patent drawingFigure 1~1F
  • EP2500351B1 patent drawingFigure 2~2H
  • EP2500351B1 patent drawingFigure 3~3I

AI summary

The present invention relates to human laminin α2 chain LG3 domain and active peptides promoting cell adhesion, spreading, migration, and neurite outgrowth. More particularly, it was found that when nerve cells are incubated using human laminin α2 chain LG3 domain and active peptides in the LG3 domain, cell adhesion, spreading, migration, and neurite outgrowth of nerve cells promote and the promotion of cell adhesion, spreading, migration, and neurite outgrowth of nerve cells are integrin-mediated and achieved by the activation of PKCδ and FAK phosphorylation. Thus, the present invention can be very useful for researches on cell adhesion, spreading, migration, and neurite outgrowth activities of cells which are focused on nerve cells and mediated by various extracellular matrix proteins including laminin, manufacture of artificial nerve conduits, burns treatment, wounds treatment, and tissue regeneration.